Search

everythinglearnresearchcommunity

for

Search:↓

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Finasteride treatment should be personalized to individual mental profiles.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Human scalp hair follicles can produce and respond to several hormones, affecting hair growth and pigmentation.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Biodegradable scaffolds help regenerate wounds and hair by activating the immune system.

Stress can slow hair growth and affect skin color by impacting the body's stress response system.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

Atopic dermatitis increases the risk of some autoimmune diseases.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Data-driven methods can help understand microbiota's role in diseases and develop personalized treatments.

Regenerative medicine may offer long-lasting relief for chronic pain and neuro-degenerative conditions.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Omics techniques are needed to understand the scalp microbiome's role in alopecia areata for new treatments.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

ILC1-like cells may contribute to hair loss in alopecia areata.

Immunological treatment improved both neuropathy and alopecia.

Higher inflammation markers are linked to more severe alopecia areata.

Current SLE classifications need refinement, and the complement system is a key therapeutic target.

People with skin conditions like psoriasis and eczema have higher anxiety levels.

MicroRNAs could lead to new treatments for skin diseases, but more research is needed.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.